Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No visible changes to the page content or study details.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now lists Revision: v3.4.2 as an addition and Revision: v3.4.1 as a deletion. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedPlatform revision updated from Revision: v3.4.0 to v3.4.1; no substantive changes to the study content, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a Show glossary option in the page header and updated the text labels for QC status, No FEAR Act data, and the revision footer (Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0). Removed the corresponding lowercase/older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.2%

- Check66 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. This is a minor metadata update that does not alter the study content or its presentation.SummaryDifference0.0%

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.